LABANCA, CATERINA
 Distribuzione geografica
Continente #
NA - Nord America 50
EU - Europa 38
AS - Asia 21
Totale 109
Nazione #
US - Stati Uniti d'America 50
IT - Italia 19
SG - Singapore 16
DE - Germania 5
FI - Finlandia 4
GB - Regno Unito 4
NL - Olanda 3
CZ - Repubblica Ceca 2
IN - India 2
FR - Francia 1
HK - Hong Kong 1
IR - Iran 1
PK - Pakistan 1
Totale 109
Città #
Chandler 11
Singapore 9
Chicago 7
Ashburn 6
The Dalles 5
London 4
Munich 4
Santa Clara 4
Paola 3
Delhi 2
Gesuiti 2
Helsinki 2
Olomouc 2
Turku 2
Amsterdam 1
Atlanta 1
Boardman 1
Hong Kong 1
Lahore 1
Landshut 1
Lawrence 1
Los Angeles 1
Princeton 1
Squillace 1
Totale 73
Nome #
miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic review 59
A Prognostic and Carboplatin Response Predictive Model in Ovarian Cancer: A Mono-Institutional Retrospective Study Based on Clinics and Pharmacogenomics 27
Belantamab mafodotin in multiple myeloma 15
Identification of ADME genes polymorphic variants linked to trastuzumab-induced cardiotoxicity in breast cancer patients: Case series of mono-institutional experience 11
The impact of PARP inhibitors in the whole scenario of ovarian cancer management: A systematic review and network meta-analysis 4
Totale 116
Categoria #
all - tutte 1.280
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.280


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202214 0 0 0 0 0 0 0 0 9 5 0 0
2022/202325 2 1 1 1 4 5 0 3 2 3 3 0
2023/202426 5 5 2 0 1 6 0 0 0 1 4 2
2024/202551 3 2 1 3 5 9 2 2 6 1 17 0
Totale 116